THIS IS A SMALL BUSINESS SOURCES SOUGHT NOTICE REPRESENTING A MARKET SURVEY AND IS NOT A REQUEST FOR PROPOSALS, PROPOSAL ABSTRACTS, QUOTATIONS OR INVITATION FOR BIDS The Department of Veterans Affairs is conducting a sources sought to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are Service-Disabled Veteran-Owned, Veteran-Owned, Small Business, HUB Zone 8(a), Women-Owned, or small disadvantaged business concerns; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice. Small businesses concerns shall be capable of providing the necessary equipment and personnel to furnish service in the volume required for all the items under this contract. Contractor shall meet all requirements of Federal, State or City codes regarding operations of this type of service. The NAICS code is 325412 Pharmaceutical Preparation Manufacturing The intent of this notice is to determine the availability of qualified commercial sources technically capable of providing the items below: 1) Radiopharmaceutical Nuclear Medicine (See Attached) Potential offerors having the skills, experience, professional qualifications, and capabilities necessary to perform the described requirement are invited to provide a capabilities statement via e-mail. The Capability statements shall not exceed three (3) pages and must include the following: 1) Company name and Point of Contact information (address, telephone, e-mail, web-site, etc.); 2) DUNS number and CAGE code; 3) Small Business Size/Certification (to include 8(a), HUB Zone, SDVOSB, etc.); and (4) Familiarity and product knowledge. Responses are due no later than 5:00 pm EST, Friday, August 1, 2014, and shall be electronically submitted to: [email protected]. All responses will be used to determine the appropriate acquisition strategy for a potential future acquisition. Response is strictly voluntary; no reimbursement will be made for any costs associated with providing information in response to this synopsis or any follow-up information requests. Product Strength/size Packaging Est. BaseYr Vol Bulk Tc-99m Sodium Pertechnetate 100 mCi MD vial 365 mult-dose Tc-99m Sodium Pertechnetate 30 mCi unit dose 75 unit doses Tc-99m MDP (Medronate) 20 mCi unit dose 450 unit doses Tc-Mertiatide (MAG3) 1-10 mCi unit dose 125 unit doses Tc-99m DTPA 1-40 mCi unit dose 465 unit doses Kit for preparation of Tc-99m DTPA 1 vial 24 vials Kit for preparation of Tc-99m PYP 5 vials Kit 30 kits Kit for preparation of Tc-99m MAA 1 vial 24 vials Kit for preparation of Tc-99 Mebrofenin 1 vial 12 vials Tc-99m sulfur colloid 1-8 mCi unit dose 150 unit doses Micro Tc99m sulfur colloid 50-300uci unit dose 75 unit doses Tc-99m MAA 1-8 mCi unit dose 465 unit doses Tc-99m Mebrofenin 8 mCi unit dose see *1 Tc-99m Disofenin 8 mCi unit dose see *1 Tc-99m Sestamibi 25 mCi unit dose 60 unit doses Tc-99m Sestamibi 10 mCi unit dose see *2 Tc-99m Sestamibi 40 mCi unit dose See *2 Tc-99m Tetrofosmin 10mCi unit dose see *2 Tc-99m Tetrofosmin 40 mCi unit dose see *2 T1-201 3-5.0 mCi unit dose see *2 Tc-99m Ceretec WBC Labeling 15-30 mCi unit dose 30 unit doses Tc-99m Ceretec 20-25mCi unit dose 1 unit doses Tc-99m Succimer (DMSA) 5 mCi unit dose 1 unit doses NaI-123 Diagnostic Capsule 100 uci capsule 30 capsules NaI-123 Diagnostic Capsule 200 uci capsule 110 capsules NaI-123 Diagnostic Capsule 350 uci capsule 30 caps In-111 Satumomab Pendetide (Octreoscan) 6 mCi unit dose 20 unit doses In-111 Capromab pendetide (Prostascint) 5 -6 mCi unit dose 15unit doses In-111 pentetate (DTPA) 1.5 mCi vial 3 vials In-111 Platelet Labeling 500 uci unit dose 3 unit doses Ga-67 Gallium Citrate 1-8 mCi unit dose 4 unit doses NaI-131 Diagnostic Capsule 0.005-4 mCi unit dose 30 unit doses NaI-131 Therapeutic Capsule 5-30 mCi unit dose 30 patients/yr NaI-131 Therapeutic Capsule 31-300 mCi unit dose 5 patients/yr I-123 MIBG (AdreView) 10 mCi unit dose 5 unit doses SIR-Spheres Y-90 Microspheres 50-85 mCi unit dose 1 unit doses WBC Collection Kit (if applicable) 1 per labeling 33 labeling Sr-89 Strontium (Metastron) 1-4 mCi syringe see *3 Sm-153 Quadramet 45-90 mCi unit dose see *3 I-123 Ioflupane 5 mCi unit dose 12

Bid Protests Not Available